TCBIO

Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 57.72 M72.22 M106.29 M139.51 M139.61 M 457.63 M Gross profit 247.68 M246.48 M277.46 M316.35 M305.48 M 1.15 B Operating expenses 55.75 M67.56 M61.37 M61.38 M58.03 M 248.34 M Selling/general/admin expenses 55.57 M67.23 M58.78 M60.55 M56.09 M 242.65 M Research & development ————— — Operating income 191.94 M178.92 M216.1 M254.98 M247.45 M 897.44 M Non-Operating Income, Total 5.59 M-2.05 M166 K00 -1.89 M Interest expense, net of interest capitalized 257.96 M199.5 M189.62 M189.38 M191.25 M 769.75 M Non-Operating Income, excl. Interest Expenses -252.37 M-201.55 M-189.45 M-189.38 M-191.25 M -771.63 M Unusual income/expense ————— — Pretax income 93.52 M60.46 M102.19 M137.78 M132.28 M 432.71 M Equity in earnings ————— — Taxes 22.5 M13.41 M24.86 M32.57 M31.63 M 102.47 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 71.02 M47.05 M77.33 M105.21 M100.66 M 330.24 M Discontinued operations ————— — Net income 71.02 M47.05 M77.33 M105.21 M100.66 M 330.24 M Dilution adjustment 00000 0 Preferred dividends 4.31 M4.31 M4.31 M4.31 M4.31 M 17.25 M Diluted net income available to common stockholders 66.71 M42.73 M73.02 M100.9 M96.35 M 312.99 M Basic earnings per share (Basic EPS) 1.450.931.592.212.13 6.86 Diluted earnings per share (Diluted EPS) 1.430.921.582.182.11 6.79 Average basic shares outstanding 46.56 M46.12 M45.79 M45.71 M45.64 M 183.26 M Diluted shares outstanding 46.99 M46.62 M46.22 M46.23 M46.13 M 185.19 M EBITDA -718 K-3.12 M44.38 M78.76 M86.45 M 206.46 M EBIT -16.03 M-12.34 M29.93 M66.13 M70.58 M 154.29 M Cost of revenue 18 M17 M15 M12 M11 M 55 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 15.31 M9.22 M14.45 M12.62 M15.88 M 52.17 M